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Limits of normalAim: To test the applicability of the published reference equations in healthy non-smoker Tuni-
sian aged 19–90 years.
Population and methods: Published reference equations were applied to the spirometry results of
540 adults (364 women). Two methods of comparison were applied: (i) Determination, according
each equation, of the percentages of subjects having a deltaLungAge (=ELA–CLA) > Upper-
Limit-of-Normal (ULN). (ii) Bland and Altman comparison, for the same age range as in the cor-
responding study, between CLA and ELA.
Results: The mean ± SD (95% conﬁdence interval) of the total sample CLA and height were
48.8 ± 13.1 (47.7–49.9) years and 164 ± 10 (163–165) cm. (i) The percentages of healthy subjects
with a deltaLungAge > ULN varied from 1% (Newbury) to 64% (Hansen) in men, and from
20% (Yamaguchi) to 51% (Hansen, Morris and Temple) for women. (ii) Mean ± SD ELA was sig-
niﬁcantly underestimated by 17 ± 19 years (Hansen), by 12 ± 23 years (Morris and Temple) and
was signiﬁcantly overestimated by 4 ± 19 years (Newbury). Mean ± SD ELA from Yamaguchi
et al. [10] was not statistically different from the CLA (1 ± 14 years).
Conclusion: The published reference equations did not reliably predict CLA data in the Tunisian
population. Awaiting the establishment of reliable equation proper to North African population,
we recommend the use of the Yamaguchi et al.’s [10] reference equations.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Smoking, shown to be detrimental to health for many years
[1–4], has an adverse effect on the ﬁrst second forced expira-
tory volume (FEV1) throughout a lifetime, reducing the max-
imal FEV1 achieved, bringing forward the age of onset of
decline in FEV1, and hastening the rate of decline [5]. The
single most useful intervention to improve lung function in
smokers, with or without, chronic obstructive pulmonary dis-
ease is smoking cessation. One way to increase the quit rate
in smokers could be to communicate about the lung function
results in a manner that is easily understood and stimulates
the desire to quit.
Estimated lung age (ELA) is an estimate that uses the ob-
served spirometric variable (often FEV1) of a smoker to calcu-
late the approximate age of a healthy non-smoker with the
same spirometric variable based on predicted values [6]. ELA
reference equations were developed as an aid for smoking ces-
sation counseling and the concept has been explored in several
recent publications [7–11]. Interpretation of ‘‘lung age’’ data
relies upon comparison of the chronological lung age (CLA)
values with ELA predicted from available reference equations
[7–10]. To our knowledge, only four studies have published
equations predicting ELA [7–10]. These equations were ﬁrst
developed by Morris and Temple in 1985 for the USA popula-
tion [7] using earlier American predictive equations for spirom-
etry published in 1971 [12]. Four models of ELA reference
equations were developed and the most relevant model to
determine ELA values was the one using FEV1 [7]. In 2010,
two other reference equations were developed by Newbury
et al. [8] and by Hansen et al. [9], respectively, for the South
Australian and USA populations. In 2012, Yamaguchi et al.
[10] have developed for the Japanese population, novel regres-
sion equations predicting lung age from varied spirometric
parameters.
These four studies used limited methodology:
Low sample size (i.e., only 125 subjects were included in the
Australian study [8]),Sample may not be representative of a normal population
(i.e., 79% of Morris and Temple [7] subjects were from 2
church groups in rural USA, subjects of the South Austra-
lian study [8] maintain a high level of ﬁtness and have occa-
sional occupational exposures to smoke when attending
ﬁres),
Use of old data (i.e., predictive equations [12] for Morris
and Temple study that are the basis of the Morris ELA
equations [7] are 41 years old; the Third National Health
And Nutrition Evaluation Survey (NHANES-3) [13,14]
data that Hansen et al. [9] equations are based on are
now approximately 20 years old),
Skewed age distribution (i.e., results of Morris and Temple
study [7] are biased towards younger ages and the age dis-
tribution is strongly skewed to the right with over 30% of
subjects aged between 20 and 30 years),
Use of old equipment and application of old spirometric methods
(i.e., Morris and Temple’s [7] and Hansen et al.’s [9] results
were calculated using equipment (respectively, stead-wells
and dry rolling-seal spirometers) and methods that give lower
results than those currently recommended by the American
Thoracic and European Respiratory Societies (ATS/ERS)
[15–17]). The study of Newbury et al. [8] predates the ﬁrst
ATS guidelines on spirometry [18] and not the last ones of
2005 [15–17]),
Mathematical and statistical ﬂaws (i.e., Morris and Temple
[7] method having a couple of mathematical and statistical
ﬂaws, lung age was an estimated value based on the popu-
lation mean [8], application of a circular argument [9] with
equations predicting the actual mean age of the subjects
from whom they were derived),
Different models of reference equations (i.e., different spiro-
metric parameters were included in the reference equations:
only FEV1 [7,8], only ratio between FEV1 and forced vital
capacity (FVC) [9], various spirometric parameters such as
FVC, FEV1, FEV1/FVC, peak expiratory ﬂow (PEF),
forced expiratory ﬂow when x% of FVC has been exhaled
(FEFx, FEF50 and FEF25 and maximal mid-expiratory
ﬂow (MMEF)) [10]),
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porting the idea that the relationship between lung ageing
and various spirometric parameters can be approximated
by a linear function [4]),
Wide variation in ELA (i.e., quite wide variability of
spirometry results of normal healthy subjects (80–120%
predicted) [8], and consequently wide variation in ELA,
exists [8]), and
Data interpretation (i.e., only two authors [7,10] have
proposed an algorithm for judging the abnormality from spi-
rometry ELA with presentation of a recommended sequence
to interpret ELA [7] or a recommendation to use the Upper-
Limit-of-Normal and Lower-Limit-of-Normal (ULN, LLN,
respectively) [10], as recommended for spirometry [19]).
These methodological shortcomings explain some discrep-
ancies in the ﬁndings. Indeed, Newbury et al. [8] have shown
that Morris and Temple [7] equations signiﬁcantly underesti-
mate CLA in both never-smokers and smokers and that
ELA by new Australian equations [8] produces ELAs that
are approximately 20 years greater than does the Morris and
Temple [7] equations, for South Australian never-smoking
and current smoking males. Of greater concern is that, in the
smoker subgroup of Newbury et al. [8], the ELA mean by
the Morris and Temple [7] equations was 12 years lower than
the CLA mean, indicating a ‘protective’ effect of tobacco
smoking. A couple of authors, however, questioned whether
the ELA was truly useful as a tool for motivating the cessation
of smoking [20,21]. They asserted that the ELA from the meth-
od of Morris and Temple [7] entirely disregarded the variabil-
ity of FEV1 in normal subjects, thus causing a physiologically
serious ﬂaw, i.e., the ELA of a normal person whose FEV1 is
below the reference value but above the LLN is forcibly esti-
mated to be older than his/her CLA, though the ELA of this
person should be equal to the CLA. This happens because
the ELA is calculated by counting back the regression equa-
tion predicting the reference value, but not the LLN, of FEV1.
How to evaluate ‘‘spirometric’’ ELA and what method is
approvable? This question was asked by some authors in
2011 [22], in order to promote the development of ethnic-spe-
ciﬁc ELA regression equations in various races. The need for
normal values speciﬁc to North African populations has been
demonstrated for several physiological parameters [23–29]. So,
the applicability and the reliability of published ELA reference
equations [7–10] should be assessed as regards the North Afri-
can adult population, in order to avoid erroneous clinical
interpretation of ELA data in this population.
The aim of the present paper is to test the applicability of
the previously published ELA reference equations [7–10] in
healthy adult North African population, represented by Tuni-
sian subjects (the null hypothesis is that there will be no differ-
ence between CLA and ELA mean values).Design and methods
Study design
We performed this cross-sectional study over a one year period
(February 2011–January 2012) in the 2 Functional Explora-
tion Laboratories at the Occupational Medicine Group
and at the Farhat HACHED Hospital of Sousse(altitude < 100 m), Tunisia. Approval for the study was ob-
tained from the Hospital Ethics Committee and a written in-
formed consent was obtained from all study participants.
Study population
Target population consists of a sample of subjects aged 19 years
and more, living in Sousse, Tunisia. Subjects were recruited
from local workers visiting the Functional Exploration Labora-
tory at the OccupationalMedicine Group of Sousse, or from the
staff of the Faculty of Medicine and the Farhat HACHED
Hospital in Sousse, as well as acquaintances of people involved
in the study. The Functional Exploration Laboratory at the
Occupational Medicine Group of Sousse offers several explora-
tions (electrocardiogram, visual test, audiogram and spirome-
try) as a routine service to local workers (subjects or patients).
Approximately 5000 spirometry procedures are performed
annually and workers are addressed by occupational physicians
for several reasons: record review of employment, working in a
risk position (i.e., dust, glue, etc.), further investigation of a
complaint (i.e., dyspnea, cough, etc.), control of a known respi-
ratory illness, and cigarettes or narghile smoking. The main rea-
son of performing spirometry was undergoing the general health
screening examination. The Functional Exploration Depart-
ment of Farhat HACHED Hospital offers several explorations
(spirometry, plethysmographie, bronchial hyper-responsiveness
test, exercise testing, etc.) as a specialized service to local subjects
or patients. Approximately 8000 cardio-respiratory procedures
are performed annually and subjects are addressed by physi-
cians for several reasons, especially cardio-respiratory com-
plaints. Reasons for performing spirometry as well as other
clinical details were not analyzed further.
Sample size
It was calculated using the following predictive equation [30]:
n= (Z2ÆpÆq)/D2, where n is the number of subjects necessary,
Z is the 95% conﬁdence level (Z= 1.96), p is the prevalence
of healthy non-smoker adult population aged more than
19 years and free from disease, which is of the order of 60%
in Tunisia according to a recent study [31], q is equal to
‘‘1 –– p’’ and D is the precision(=4.5%). According to this for-
mula the number of subjects required was 455.
Inclusion and non-inclusion criteria
Only healthy and ‘‘normal’’ subjects aged between 19 and
90 years, having complete records and a technically acceptable
and reproducible spirometry maneuvers were included in the
study.A healthy and ‘‘normal’’ person is deﬁned as one inwhom
there is [32,33]: (i) no presence of acute and no past chronic dis-
ease of the respiratory system; (ii) no major respiratory disease,
such as congenital anomalies, destructive type of pneumonia or
thoracic surgery in past medical history; (iii) no systemic disease
whichmay directly or indirectly inﬂuence the respiratory system
and general state of health (e.g., cardiovascular, neuromuscular,
skeletal or renal disease); (iv) no history of upper respiratory
tract infection during three weeks prior to investigation; (v) no
underweight, no severe or massive obesity; (vi) Lifelong non-
smokers (cigarettes and/or narghile) or no more than incidental
smoking experience. Added non-inclusion criteria were respira-
792 H. Ben Saad et al.tory work exposure and an abnormal spirometric data (FEV1
and/or FVC and/or FEV1/FVC ratio < LLN).
Collected data
CLA from identity card, sex (men, women), anthropometric
data (age, weight, height, Body Mass Index (BMI)), parity, spi-
rometric data (FVC, FEV1, PEF, MMEF, FEF75, FEF50,
FEF25, FEV1/FVC ratio), ELAs from the published studies
[7–10]. The study protocol was as follows: welcome and provi-
sion of an information sheet; completion of medical question-
naire, and anthropometric and spirometric measures.
Medical questionnaire, tobacco use evaluation
Data were collected using a simpliﬁed non-validated version of
a medical questionnaire recommended for epidemiological re-
search [34]. It was composed of questions (mainly closed ques-
tions, usually dichotomous) put to the subjects in local Arabic
dialect. It was used to assess subject characteristics: cigarette
smoking and narghile use [35–37], medical, surgical, and gyne-
cologic-obstetric histories and medication use.
Anthropometric measurements
The decimal age (accuracy to 0.1 years) was calculated from the
date ofmeasurement and the date of birth [38].Due to the failure
of software to compute decimal age as the difference between
test date and birth date, age was taken as the number of com-
plete years from birth to the date of the study. Standing height
and weight were measured using a stadiometer and expressed
to the nearest centimeter and kilogram, respectively. Depending
on calculated BMI (kg/m2), we distinguished between [39]:
underweight (BMI < 18.5), normal weight (18.5 6 BMI < 25),
overweight (25 6 BMI < 30) and obese (BMIP 30). The latter
was either moderate (30 < BMI < 35), severe (35 6 BMI <
40), or massive (BMIP 40).
Spirometry function tests
Spirometrywas carried out in the sitting position, and anose clip
was applied. To avoid the problem of variability due to differentBox 1. Published ELA reference equations
Morris and Te
Men
ELA = 2.331 x Height (cm) - 40.000 x Obse
ELA = 1.130 x Height (cm) - 31.250 x Obse
ELA = 0.411 x Height (cm) - 22.222 x Obse
Women
ELA = 1.887 x Height (cm) - 41.667 x Obse
ELA = 1.401 x Height (cm) - 40.000 x Obse
ELA = 0.787 x Height (cm) - 33.333 x Obse
Newbury et 
Men: ELA = 1.56 x Height (cm) - 33.69 x Observed 
Women: ELA = 1.33 x Height (cm) - 31.98 x Observ
Hansen et 
Men and women: ELA = CLA + 3 x (predicted-obse
Yamaguchi et
Men: ELA = 209.195 - 0.455 x Height (cm) - 11.5
FEV1/FVC (%) + 1.956 x Observed FEF50 (l/s)
Women: ELA = 234.441 - 0.792 x Height (cm) - 7.
FEV1/FVC (%) + 0.301 x Observed PEF (l/s) + 2.647technicians and devices [15], all tests were performed, between
9.00 am and 1.00 pm, by only two qualiﬁed persons (one person
at each site). All subjects performed spirometry on a dry rolling
seal spirometer (Spida5; Micro Direct, Inc. 803 Webster Street
Lewiston, ME 04240). The ﬂow sensor of the spirometer, which
was calibrated daily with a 3-liter syringe (to ensure perfor-
mance), is a hot-wire anemometer, and the range of air ﬂow lin-
earity is 0.01–16.00 l/s with an accuracy of ±3% between 0.01
and 12.00 l/s. Spirometry was performed according to the recent
international recommendations [15]. The spirometric data
(FVC (l); FEV1 (l); FEFx (l/s), PEF (l/s), FEV1/FVC ratio (abso-
lute value)) were expressed at ‘‘body temperature, barometric
pressure saturated with water vapor’’ [15–17]. LLN for spiro-
metric data was calculated from the local spirometric norms
[26–28]. Any observed value for FEV1, FVC and FEV1/FVC ra-
tio lower than its corresponding LLNwas considered abnormal.
Data analysis
Expression modes of results
The Kolmogorov–Smirnov test was used to analyze distribu-
tion of variables [30]. When the distribution is normal and
the variances are equal, the results are expressed by their
mean ± standard deviation (SD) and 95% conﬁdence interval
(95% CI). If the distribution is not normal, the results are ex-
pressed by their medians (1st–3rd quartiles). The chi-2 test was
used to compare percentages. Preliminary descriptive analysis
included frequencies for categorical variables (sex) and
mean ± SD (or median (1st–3rd quartiles)) for continuous ones
(anthropometric and spirometric data).
Published ELA reference equations (Box 1)
Morris and Temple [7] have developed 6 reference equations
models for the USA population aged 20–84 years. Newbury
et al. [8] have developed 2 reference equations models for the
South Australian population aged 25–74 years. Hansen et al.
[9] have developed only one reference equation model for the
USA population aged 20–80 years. FEV1/FVC (%) for normal
USA never-smoking adults were independent of ethnicity and
sex [40,41] and equal to 98.8–0.25 · Age (years) –– 1.79 · FVC
(l). Yamaguchi et al. [10] have developed 2 reference equations
models for the Japanese population aged 25–87 years.mple [7]
rved FVC (l) - 169.640
rved FEV1 (l) - 39.375
rved MMEF (l/s) + 55.844
rved FVC (l) -118.833
rved FEV1 (l) - 77.280
rved MMEF (l/s) + 18.367
al. [8]
FEV1 (l) - 85.62
ed FEV1 (l) - 74.65
al. [9]
rved) FEV1/FVC ratio (percentage)
 al. [10]
21 x Observed FEV1 (l) - 0.602 x Observed 
295 x Observed FEV1 (l) - 0.610 x· Observed 
 x Observed FEF50 (l/s)
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Four methods were applied.
(i) Student’s t-test was used to compare CLA versus
ELA.
(ii) We have determined, according to each reference equa-
tion [7–10], the number (%) of healthy subjects with
ELA ‘‘clinically and signiﬁcantly’’ higher than the
CLA. According to Yamaguchi et al. [10], ELA is con-
sidered as ‘‘clinically and signiﬁcantly’’ higher than the
CLA, when the delta lung age (delta LA = ELA ––
CLA) is higher than the ULN equal to 13.4 years in
men or 15.0 in women.
(iii) We have determined according to each reference equa-
tion and for the same age range as in the corresponding
studies [7–10], the number (%) of healthy subjects with
ELA below zero or over 110 years.
(iv) Graphical comparison with published reference equa-
tions [7–10]: CLAs were compared with ELAs calcu-
lated from the published reference equations [7–10]
for the same age range as in the corresponding study,
in several ways. First, our CLA values were compared
with ELA calculated from the published reference
equations [7–10] using scatter plots and paired t tests.
Second, as proposed by Bland and Altman [42], com-
parisons between CLA and ELA were performed by
means of the limits of agreement, where individual dif-
ferences (delta LA) were plotted against the corre-
sponding mean value. From these data, limits of
agreement were then calculated (mean delta
LA ± 1.96 SD) [42]. The reference equation that pro-
vides the limits of agreement closest to zero will be
the most appropriate for our population.
Analyses were carried out using Statistica software (Statis-
tica Kernel version 6; StatSoft, Paris, France). Signiﬁcance was
set at 0.05 level.Figure 1 Distribution of the total sample by sex and age ranges.
*p< 0.05 (Chi-2): men vs. women. NS: non signiﬁcant.Results
Descriptive data
Non-inclusion criteria
An initial sample of 667 adult volunteers was examined. Non-
inclusion criteria, presented in detail in E.Table 1 (Supplemen-
tary data) were found in 129 subjects.
Anthropometric and spirometric data
The dependent variable (CLA) was normally distributed
(Kolmogorov–Smirnov = 0.066, p< 0.05). Fig. 1 shows the
age and sex distribution of the 540 healthy subjects (176
men). We note a signiﬁcantly large number of women included
in the age ranges between 19.0 and 60.0 years. Table 1 exposes
the anthropometric and spirometric data of the included
healthy subjects. When compared with men, women were sig-
niﬁcantly more aged, signiﬁcantly shorter and had a signiﬁ-
cantly higher BMI. Expressed in percent of local predicted
values, all women observed spirometric data were signiﬁcantly
higher than those of men, except for the FEV1/FVC ratio and
FEF50 variables.Analytical data
ELA data
Table 2 exposes the comparison between CLA and ELA deter-
mined from the published reference equations.
ELAs from Newbury et al.’s reference equations are signif-
icantly different from the CLAs (overestimated by 19 years in
men, underestimated by 4 years in women and overestimated
by 4 years in the total sample).
ELAs from Hansen et al.’s reference equation are signiﬁ-
cantly lower than the CLAs (underestimated by 17, 16 and
16 years, respectively for men, women and the total sample).
ELAs from Yamaguchi et al.’s reference equations are sig-
niﬁcantly different from CLAs for men and women (respec-
tively, overestimated by 9 years and underestimated by
5 years). However, the total sample ELA was not statistically
different from the CLA.
ELAs from Morris and Temple’s reference equation model
using FEV1 are signiﬁcantly lower than the CLAs for women
and the total sample (underestimated by 18 and 11 years,
respectively). However, the men’s ELA was not statistical dif-
ferent from the CLA.
ELAs from Morris and Temple reference equation model
using FVC are signiﬁcantly different from CLAs for men
and women (respectively, overestimated by 19 years and
underestimated by 8 years). However, the total sample ELA
was not statistically different from the CLA.
ELAs from Morris and Temple reference equation model
using MMEF are signiﬁcantly lower than the CLAs (underes-
timated by 11, 29 and 23 years, respectively for men, women
and the total sample).
ELAs from Morris and Temple reference equation model
using the mean of the 3 above models are signiﬁcantly different
from CLAs for men, women and total sample (respectively,
overestimated by 3 years, underestimated by 18 years and
underestimated by 11 years).
Number of healthy subjects with abnormal ELA
Table 3 presents, according to the published reference equa-
tions, the number (%) of healthy Tunisian subjects with
Table 1 Anthropometric and spirometric data.
Men (n= 176) Women (n= 364) Total sample (n= 540)
Age (Year) a 45.4 ± 15.5 (43.1–47.8) 50.5 ± 11.4* (49.3–51.6) 48.8 ± 13.1 (47.7–49.9)
Height (cm) a 166 ± 8 (165–167) 163 ± 11* (162–164) 164 ± 10 (163–165)
Weight (kg) a 74 ± 12 (72–76) 73 ± 12 (72–74) 73 ± 12 (72–74)
Body Mass Index (kg/m2) a 26.8 ± 3.8 (26.2–27.4) 27.5 ± 3.5* (27.1–27.9) 27.3 ± 3.6 (27.0–27.6)
Parity (numerical) a 5 ± 3 (4–5)
Normal weightb 58 (33%) 88 (24%) 146 (27%)
Overweightb 81 (46%) 178 (49%) 259 (48%)
Moderate obesityb 37 (21%) 98 (27%) 135 (25%)
1st second forced expiratory volume (FEV1, l)
a 3.22 ± 0.62 (3.13–3.32) 2.97 ± 1.00* (2.87–3.07) 3.05 ± 0.90 (2.98–3.13)
FEV1 (% predicted)
a 97 ± 11 (96–99) 114 ± 21* (112–116) 109 ± 20 (107–110)
Forced vital capacity (FVC, l) a 3.81 ± 0.72 (3.70–3.92) 3.51 ± 1.19* (3.38–3.63) 3.61 ± 1.07 (3.52–3.70)
FVC (% predicted)a 95 ± 11 (93–96) 114 ± 22* (112–117) 108 ± 21 (106–110)
FEV1/FVC (absolute value)
a 0.85 ± 0.06 (0.84–0.86) 0.85 ± 0.06 (0.84–0.86) 0.85 ± 0.06 (0.84–0.85)
Peak expiratory ﬂow (PEF, l/s)a 7.32 ± 1.58 (7.08–7.56) 6.45 ± 2.23* (6.22–6.68) 6.73 ± 2.08 (6.56–6.91)
PEF (% predicted)a 88 ± 19 (85–91) 100 ± 27* (97–103) 96 ± 25 (94–98)
Forced expiratory ﬂow when 25% of
FVC has been exhaled (FEF25, l/s)
a
1.99 ± 0.74 (1.88–2.10) 1.93 ± 1.16 (1.81–2.05) 1.95 ± 1.04 (1.86–2.04)
FEF25 (% predicted)
a 111 ± 36 (106–116) 123 ± 71* (116–130) 119 ± 62 (114–124)
Forced expiratory ﬂow when 50% of
FVC has been exhaled (FEF50, l/s)
a
4.69 ± 1.37 (4.48–4.89) 4.28 ± 1.54* (4.12–4.44) 4.41 ± 1.50 (4.28–4.54)
FEF50 (% predicted)
a 103 ± 27 (99–107) 108 ± 30 (105–111) 107 ± 29 (104–109)
Forced expiratory ﬂow when 75% of
FVC has been exhaled (FEF75, l/s)
a
6.68 ± 1.55 (6.45–6.91) 5.80 ± 2.42* (5.55–6.05) 6.09 ± 2.21 (5.90–6.27)
FEF75 (% predicted)
a 92 ± 20 (89–95) 102 ± 37* (98–106) 99 ± 33 (96–102)
Maximal mid-expiratory ﬂow (MMEF, l/s)a 4.04 ± 1.13 (3.87–4.21) 3.75 ± 1.60* (3.58–3.91) 3.84 ± 1.47 (3.72–3.97)
MMEF (% predicted)a 102 ± 24 (98–105) 113 ± 40* (109–117) 110 ± 36 (107–113)
p < 0.05 (*Student-test, lChi-2): men vs. women.
a Data are mean ± SD (95% conﬁdence interval).
b Data are number (%).
Table 2 Comparison between chronological lung age (CLA) and estimated lung age (ELA) calculated from published reference
equations.
Men (n= 176) Women (n= 364) Total sample (n= 540)
CLA (Year) 45.4 ± 15.5 (43.1–47.8) 50.5 ± 11.4 (49.3–51.6) 48.8 ± 13.1 (47.7–49.9)
ELA (Year) from Newbury et al. reference equation 64.4 ± 17.9 (61.8–67.1)a 46.8 ± 21.8 (44.6–49.1)a 52.6 ± 22.2 (50.7–54.4)a
ELA (Year) from Hansen et al. reference equation 28.4 ± 20.6 (25.3–31.5)a 34.0 ± 18.8 (32.0–35.9)a 32.2 ± 19.5 (30.5–33.8)a
ELA (Year) from Yamaguchi et al. reference equation 54.8 ± 9.2 (53.4–56.2)a 45.1 ± 12.1 (43.8–46.3)a 48.2 ± 12.1 (47.2–49.3)
ELA (Year) from Morris and Temple reference equations models using:
First second forced expiratory volume 47.2 ± 16.6 (44.8–49.7) 32.2 ± 28.9 (29.2–35.2)a 37.1 ± 26.5 (34.9–39.3)a
Forced vital capacity 64.4 ± 24.2 (60.8–68.0)a 42.7 ± 34.3 (39.2–46.2)a 49.8 ± 33.0 (47.0–52.6)
Maximal mid-expiratory ﬂow 34.2 ± 24.4 (30.6–37.9)a 21.7 ± 47.4 (16.8–26.6)a 25.8 ± 41.7 (22.3–29.3)a
The mean of the 3 above models 48.6 ± 19.1 (45.8–51.5)a 32.2 ± 34.7 (28.6–35.8)a 37.6 ± 31.5 (34.9–40.2)a
Data are mean ± SD (95% conﬁdence interval).
a p< 0.05 (paired-test): CLA vs. ELA.
794 H. Ben Saad et al.ELA ‘‘clinically and signiﬁcantly’’ higher than the CLA. These
percentages varied from 1% (Newbury et al.) to 64% (Hansen
et al.) in men, and from 20% (Yamaguchi et al.) to 51%
(Hansen et al. and Morris and Temple model using MMEF),
in women. For the total sample the lowest percentages are seen
with Yamaguchi et al. and Newbury et al., respectively, 14%
and 16%. Table 3 presents also the number (%) of healthy
subjects with ELA (calculated for the same age range as in
the corresponding study) below zero or over 110 years. We
conclude that when applied in our population,(i) Yamaguchi et al.’s reference equations give no persons
with an ELA below zero or over 110 years;
(ii) Newbury et al.’s reference equations give 3% of healthy
women with an ELA below zero.
(iii) Hansen et al.’s reference equation gives 6% of healthy
men and 3% of healthy women with an ELA below
zero.
(iv) Morris and Temple’s reference equations give the high-
est percentage of healthy subjects with an ELA below
zero, especially in women.
Table 3 Number (percentage) of Tunisian healthy adults having an abnormal estimated lung age (ELA).
ELA derived from reference equation of Men Women Total sample
ELA ‘‘clinically and signiﬁcantly’’ higher than the chronological lung age (men/women:176/364)
Newbury et al. 2 (1%) 85 (23%) 87 (16%)
Hansen et al. 113 (64%) 185 (51%) 298 (55%)
Yamaguchi et al. 4 (2%) 74 (20%) 78 (14%)
Morris and Temple models using:
1st second forced expiratory volume 17 (10%) 175 (48%) 192 (36%)
Forced vital capacity 6 (3%) 139 (38%) 145 (27%)
Maximal mid-expiratory ﬂow 75 (43%) 186 (51%) 261 (48%)
The mean of the three above models 18 (10%) 154 (42%) 172 (32%)
ELA (calculated for the same age range as in the corresponding study) below zero or over 110 years
Below zero Over 110 Below zero Over 110 Below zero Over 110
Newbury et al. (men/women: 148/348) 0 (0%) 0 (0%) 11 (3%) 0 (0%) 11 (2%) 0 (0%)
Hansen et al. (men/women: 171/360) 10 (6%) 0 (0%) 11 (3%) 0 (0%) 21 (4%) 0 (0%)
Yamaguchi et al. (men/women: 154/355) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Morris and Temple models (men/women:171/361) using:
1st second forced expiratory volume 0 (0%) 0 (0%) 63 (17%) 0 (0%) 63 (15%) 0 (0%)
Forced vital capacity 1 (1%) 5 (3%) 50 (14%) 2 (1%) 51 (10%) 7 (1%)
Maximal mid-expiratory ﬂow 11 (6%) 0 (0%) 106 (29%) 0 (0%) 117 (22%) 0 (0%)
The mean of the three above models 0 (0%) 0 (0%) 82 (23%) 0 (0%) 82 (15%) 0 (0%)
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Figs. 2 and 3 show, for the same age range as in the corre-
sponding study, CLA individually plotted against the corre-
sponding ELA values predicted from reference equations of
Morris and Temple [models using FEV1 (Fig. 2A) or FVC
(Fig. 2B) or MMEF (Fig. 2C) or the mean of FEV1 and
FVC and MMEF (Fig. 2D)], of Hansen et al. (Fig. 3A), of
Newbury et al. (Fig. 3B) and of Yamaguchi et al. (Fig. 3C).
As can be seen, the data showed a wide disparity compared
with the identity line.
Figs. 4 and 5 show, for the same age range as in the corre-
sponding study, the Bland and Altman comparisons between
CLA and ELA predicted from the published reference equa-
tions. There was a systematic bias between the CLA and ELA
values for most of these equations; that is to say, the difference
with CLA increased as the ELA increased. This was particularly
evident for the equations of Morris and Temple (models using
FEV1 or MMEF or the mean of FEV1, FVC and MMEF)
(Fig. 4A, C and D, respectively), or from Hansen et al.
(Fig. 5A). The correlation between delta LA and mean values
was also signiﬁcant for theMorris andTemple’s equationmodel
using FVC (p< 0.001, Fig. 4B), and Newbury et al.’s equation
(p= 0.001, Fig. 5B). On the other hand, the correlation between
mean DLA and mean values was not signiﬁcant for the
Yamaguchi et al.’s reference equations (p= 0.16, Fig. 5C).
Second, as can be deduced fromFigs. 4 and 5, there was a differ-
ence between CLA and ELA determined from these published
reference equations, which was often statistically signiﬁcant.
Indeed, mean ± SD ELA was signiﬁcantly underestimated
by 23.0 ± 37.3 years (p< 0.001), by 16.6 ± 18.7 years
(p< 0.001), by 11.8 ± 22.8 years (p< 0.001), by
11.4 ± 27.1 years (p< 0.001) and by 1.9 ± 13.1 years
(p= 0.009), respectively, with the reference equations ofMorris
and Temple model using MMEF, (Fig. 4C); of Hansen et al.
(Fig. 5A); of Morris and Temple model using FEV1 (Fig. 4A);of Morris and Temple model using the mean of FEV1, FVC
and MMEF, (Fig. 4D); and of Yamaguchi et al. (Fig. 5C).
ELA was signiﬁcantly but slightly overestimated by
2.8 ± 19.3 years (p< 0.01) with the reference equations of
Newbury et al. (Fig. 5B). For the total sample data, mean ± SD
ELA derived from Morris and Temple model using FVC
(Fig. 4B) was not signiﬁcantly different from CLA (mean ± -
SD= 0.7 ± 29.0 years; p= 0.673). However, when exam-
ined separately, ELA derived from Morris and Temple model
usingFVCwas signiﬁcantly underestimated by 7.8 ± 29.1 years
(p< 0.001) and overestimated by 18.8 ± 18.7 years
(p< 0.001), respectively in men and women.Discussion
Published and locally applied spirometric reference equations
for ELA did not reliably predict CLA data in 540 healthy adult
subjects representing a sample of the Tunisian population. So,
we can reject the null hypothesis that we would see no differ-
ence in the means of the CLA and ELA produced by the pub-
lished reference equations [7–10]. Our results strongly suggest
that existing lung age equations [7–10] are in need of review.
Methodology discussion
Study design
As for the studies aiming to publish ELA reference equations
[7–10], ours was not a random population sample. Some cau-
tion should be warranted when interpreting the results of
cross-sectional studies in volunteers, because of a possible
selection bias and cohort effects [43]. Thus, longitudinal stud-
ies analyzed by appropriate statistical models are necessary to
correctly describe the functional changes associated with age
[18]. This was recently demonstrated by Newbury et al. [44]
who conclude that ELA using six predictive equations span-
Figure 2 Comparison, for the same age range as in the corresponding study, of chronological lung age (CLA) with estimated lung age
(ELA) determined from reference equations of Morris and Temple models using: ﬁrst second forced expiratory volume (FEV1) (Fig. A),
Forced vital capacity (FVC) (Fig. B), Maximal mid-expiratory ﬂow (MMEF) (Fig. C), The mean of FEV1 and FVC and MMEF (Fig. D).
n= number of subjects having the same age range as in the corresponding study; r: correlation coefﬁcient; p: probability. Solid line
( ): regression line; Dashed line ( ): identity line.
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Figure 3 Comparison, for the same age range as in the corresponding study, of chronological lung age (CLA) with estimated lung age
(ELA) determined from reference equations of: Hansen et al. (Fig. A), Newbury et al.(Fig. B), Yamaguchi et al. (Fig. C), n= number of
subjects having the same age range as in the corresponding study; r: correlation coefﬁcient; p: probability. Solid line ( ): regression
line; Dashed line ( ): identity line.
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Figure 4 The Bland and Altman representation, for the same age range as in the corresponding study, of chronological lung age (CLA)
with estimated lung age (ELA) determined from reference equations of Morris and Temple models using: ﬁrst second forced expiratory
volume (FEV1) (Fig. A), Forced vital capacity (FVC) (Fig. B), Maximal mid-expiratory ﬂow (MMEF) (Fig. C), The mean of FEV1 and
FVC and MMEF (Fig. D), r: correlation coefﬁcient; p: probability; n= number of subjects having the same age range as in the
corresponding study. Mean; : mean ± 1.96 ± SD; : regression line.
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Figure 5 The Bland and Altman representation, for the same age range as in the corresponding study, of chronological lung age (CLA)
with estimated lung age (ELA) determined from reference equations of: Hansen et al. (Fig. A), Newbury et al. (Fig. B), Yamaguchi et al.
(Fig. C), r: correlation coefﬁcient; p: probability; n= number of subjects having the same age range as in the corresponding study.
Mean; : mean ± 1.96 ± SD; : regression line.
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800 H. Ben Saad et al.ning 50 years showed differences attributable to cohort and
period effects. Although no statistical methods were used to
choose the volunteers, the number of subjects studied [38]
and the fact that many private or government-owned ﬁrms
in different areas of Sousse (Tunisia) were included give a rea-
sonable degree of conﬁdence in the data.
Population source
Our study design (prospective study) and our recruitment
mode were similar to those of the Japanese study [10]
(E.Table 2, supplementary data). The three other studies were
retrospective types (E.Table 2, supplementary data). The
greater percentage (85%) of our participants was sorted from
those undergoing the general health screening examination at
the Functional Exploration Laboratory at the Occupational
Medicine Group of Sousse.
Sample size and characteristics
In a recent study [38] aiming to establish the number of local
subjects required to validate published reference equations, it
was found that at least 150 men and 150 women would be nec-
essary to validate the reference equations to avoid spurious dif-
ferences due to sampling error. Our sample size (n= 540)
appears to be satisfactory since the calculated one is 455 sub-
jects. It was higher than the sample size of one study [8]
(n= 125), but was smaller than the sample sizes of other stud-
ies [n= 988 [7]; n= 7428 [9] and n= 8015 [10]) (E.Table 2,
supplementary data). Like in the Japanese study [10], our sam-
ple was dominated by women (respectively, 68.8% and
67.4%). In the 3 other studies, the percentage of included
women were, 47.7% [7], 52.8% [8] and 59.0% [9] (E.Table 2,
supplementary data). Like the South Australian sample [8],
ours was evenly age-stratiﬁed (Fig. 1). The Morris and Temple
[7] sample was strongly skewed to the right with over 30% of
subjects in the youngest 10 year age bracket.
Applied inclusion and non-inclusion criteria
As it is recommended for such epidemiological study, we have
included only healthy adults as deﬁned by international guide-
lines [32,33]. The applied inclusion and non-inclusion criteria
were different from one study to another (E.Table 3, supple-
mentary data). Only Yamaguchi et al. [10] have assessed smok-
ing durations or habits or exposure to second-hand smoke or
environmental exposures.
Spirometry measurements
As for the study of Yamaguchi et al. [10], and differently to the
other three published studies [7–9] (E.Table 3, supplementary
data), we have applied the recent international guidelines for
spirometry [15–17].
Comparison with published reference equation: to our knowl-
edge, the present study is the ﬁrst one to have tested the reli-
ability of the published ELA reference equations [7–10] on
healthy adult population having a different race (the Arab
race) than the races explored in other studies (E.Table 3, sup-
plementary data). In addition, in our study, all Morris and
Temple’s reference equations [7] are checked, which has been
done for the ﬁrst time in the literature. All previous studies
[8–10] have focused on Morris’s and Temple reference equa-
tion model‘s using FEV1 [7].Results discussion
There was a signiﬁcant difference between CLA and ELA
determined from the published reference equations [7–10]
(Figs. 4 and 5). These results provide us important informa-
tion. First, the null hypothesis that we would see no difference
in the means of the CLA and ELA produced by the published
reference equations [7–10] is rejected. Second, the application
of the published ELA reference equations [7–10] as regards
the Tunisian adult population; induce erroneous clinical inter-
pretation of ELA data in this population.
How can we explain these differences? There are several
possible reasons for this signiﬁcant result and it is possible that
all play a role (E.Tables 2 and 3, supplementary data).
Methodological reasons
Low sample size. The South Australian study [8] sample size
(n = 125 subjects) (E.Table 2, supplementary data) is lower
than the recommended sample size of 150 men and 150 women
[15]. A relatively large number of subjects (n= 300) is neces-
sary to be conﬁdent that a signiﬁcant difference between the
published reference equations and the values from the local
community does not exist [6]. The South Australian study [8]
sampling error can explain a part of the spurious differences.
Sample representation and race. There have been recommenda-
tions to perform spirometric measurements on a representative
sample of healthy subjects [16]. Seventy-nine percent of sub-
jects included in the Morris and Temple study [7] were from
two church groups in rural USA. The doctrines of these
churches forbid tobacco smoking, the intake of alcohol or caf-
feine as well as advocating a vegetarian diet. The population
sample of the South Australian study [8] was drawn from the
broad rural community, targeting non-smokers with no history
of lung disease [45]. But, retained subjects maintain a high level
of ﬁtness and contrarily have occasional occupational expo-
sures to smoke when attending ﬁres [8]. These samples [7,8]
cannot be described as representative of a ‘normal’ current
day population and may not be representative of a normal
population. Participants in the Yamaguchi et al.’s [10] study
were sorted from those undergoing the general health screen-
ing examination at the Japanese red cross kumamoto health
care center. Several studies [15–17] have demonstrated ethnic
differences in pulmonary function, and ELA reference equa-
tions based on American [7,9], South Australian [8] or Japa-
nese [10] populations may not perform well on North
African population [26,28].
Use of old data. Guidelines for spirometry [15] recommend that
reference equations should be derived from a ‘relevant’ popu-
lation and should be updated at least every 10 years. These rec-
ommendations should equally apply to ELA reference
equations. Predictive equations [12] for the American study
[7] that are the basis of the Morris and Temple ELA reference
equations are 41 years old. The NHANES-3 [13,14] data that
Hansen et al.’s [9] equations are based on were collected be-
tween 1988 and 1994, and are also now approximately 20 years
old. The cohort effect suggests that a 40 year-old today will not
be the same as someone of the same age 40 years ago due to
demographic and environmental differences [32].
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[7] are biased towards younger ages and the age distribution
is strongly skewed to the right with over 30% of subjects aged
between 20 and 30 years. One of the strengths of the South
Australian sample [8] was it is evenly age-stratiﬁed, resulting
in reference equations that are equally relevant across the
whole age range.
Use of old equipment and application of old spirometric methods.
Respiratory testing equipment and procedures have been pro-
gressively reﬁned over the last 41 years in linewith recommenda-
tions that have been regularly updated by theATS/ERS [15–17].
According to these societies, ideally spirometric reference equa-
tions should be derived from a population similar to the individ-
ual subject using the same kind of instrument and testing
procedure [15–17]. The Morris and Temple’s [7] and Hansen
et al.’s [9] results were calculated using equipment (respectively,
stead-wells and dry rolling-seal spirometers) and methods that
give different results than those currently recommended by the
ATS [19]. The study of Newbury et al. [8] predated the ﬁrst
ATS guidelines on spirometry [18]. Only Yamaguchi et al. [10]
predated recent ATS/ERS spirometry guidelines [15–17].
Other, not evaluated factors, known to inﬂuence lung function.
Other factors that also inﬂuence lung function throughout life
(gestational age at birth [46], genetics [47], childhood infections
[48], and environmental factors such as air quality and work-
place exposures [49]) were not evaluated. Also, the relationship
between ELA and parity, a particular factor in developing na-
tions [4.3 in Tunisia [50]; 1.6 in Europe and North America
[51]] has not been analyzed. In previous studies [26–28], some
authors have demonstrated that high parity accelerates pul-
monary function decline: FEV1 decreased by 84 ml when par-
ity increased by one unit. For developing countries, ELA for
women should take into consideration the parity level.
Statistical reasons
Mathematical and statistical ﬂaws. Although the original meth-
od proposed by Morris and Temple [7] has undoubtedly con-
tributed toward the smoking-cessation program [52], it had a
couple of mathematical and statistical ﬂaws. Since the ELA
from spirometric measurements is absolutely important when
considering the enlightenment concerning chronic obstructive
pulmonary disease and smoking cessation, it is indispensable
to establish the reliable method allowing estimation of spiro-
metric lung age [22,53]. In addition, in the South Australian
study [8], lung age was an estimated value based on the popu-
lation mean. This has potential difﬁculties when predicting val-
ues for individuals. This was demonstrated by the large SD of
ELA for never-smokers (18.66 years) or current-smokers
(22.52 years) derived from the South Australian ELA reference
equations [8]. Hansen et al. [9] have applied a circular argu-
ment: equation predicts the actual mean age of the subjects
from whom they were derived.
Different models of ELA reference equations. Morris and Tem-
ple [7] and Newbury et al. [8] have included only FEV1 in their
reference equations and have presented different models for
men and women. Hansen et al. [9] have chosen to include only
FEV1/FVC ratio that is independent of ethnicity and gender[40,41]. They have justiﬁed their choice by the fact that in nor-
mal American populations, the FEV1/FVC ratio has much less
variability than absolute measures of other spirometric vol-
umes or ﬂows [54]. It is indistinct whether the ELA can be reli-
ably predicted simply from one spirometric parameter, often
FEV1 [53]. For that reason, Yamaguchi et al. [10] have in-
cluded various spirometric parameters as explanatory
variables.
Linear function and ageing. There are no reliable grounds for
supporting the idea that the relationship between the ageing
lung and various spirometric parameters can be approximated
by a linear function. Kohansal et al. [4] demonstrated that, in
the male, peak of FEV1 or FVC would be attained at an age
between 20 and 25 years-old and then would decline with
age, but, in the female, full lung growth would be achieved ear-
lier than in the male. In practice, reference equation should be
derived by valid and biologically meaningful statistical models,
taking into account the dependence of lung function with age
and height [16]. Furthermore, the backward calculation of age
from the regression equation for the reference value of FEV1
may not be allowed in a statistical sense [22,53,55]. For exam-
ple, when the original method of Morris and Temple [7] is ap-
plied, the ELA of a person with measured FEV1 beyond ULN
results in being remarkably young (sometimes, below zero),
while that of a person with FEV1 below LLN is estimated as
being very elderly (sometimes, over 100) [53] (table 3).
Wide variation in ELA. The variability of South Australian spi-
rometry results of normal healthy subjects was quite wide (80–
120% predicted) and consequently a wide variation in ELA ex-
ists [8].
Data interpretation ways. Publications on reference equations
should include explicit deﬁnitions of the ULN and LLN, or
provide information to allow the reader to calculate a lower
range [16]. Only two authors [7,10] have proposed an algo-
rithm for judging the abnormality from spirometry ELA. Mor-
ris and Temple [7] have presented a recommended sequence to
interpret ELA and Yamaguchi et al. [10] have recommended
the use of ULN and LLN [19].
How to evaluate ‘‘spirometric’’ ELA for North African
population? What method is approvable?
First of all, our results strongly suggest that existing ELA ref-
erence equations [7–10] are in need of review. These results fur-
ther conﬁrm the need to use modern lung age equations which
will provide a stronger message in smoking cessation counsel-
ing. That is to say that their use in North African population
induces erroneous clinical interpretation of ELA. So, and as it
is recommended by international guidelines [16] that encour-
age investigators to develop and publish speciﬁc spirometric
reference equations for healthy individual, it is time to set
the North African ELA reference equations.
Second, from the published reference equations [7–10], and
waiting the establishment of reliable equation proper to North
African population, we recommend the use of the equations
presented by Yamaguchi et al. [10] for healthy subjects aged
25–87 years. Our recommendation is based on the following
reasons.
Figure 6 Five-step procedure for judging the abnormality of
estimated lung age (ELA) in North African population. For
abbreviations, see list of abbreviations.
802 H. Ben Saad et al.(i) The Yamaguchi et al.’s [10] study, the only prospective
one, concerns the biggest sample size (E.Table 2, supple-
mentary data).
(ii) The study methodology and the statistical approach [10]
to determine ELA reference equations are very satisfy-
ing (E.Table 2, supplementary data).
(iii) Since their reference equations include FEV1/FVC and
FEFx as explanatory variables, they are expected to be
sensitive to the functional abnormality caused by the
interstitial lung pathology, as well [10].
(iv) Yamaguchi et al. [10] were the only authors who have
presented a clear algorithm for judging the abnormality
from spirometry-derived lung age (E.Table 2, supple-
mentary data).
(v) When applied in our Tunisian healthy adult population,
the total sample CLA was equal to ELA determined
from the Japanese equations [10] (Table 2). Also, among
the four published studies [7–10], Yamaguchi et al. [10]
gives the lowest percentage of subjects with ELA ‘‘clin-
ically and signiﬁcantly’’ higher than the CLA and no
subjects with an ELA lower than zero or over 110 years
(Table 3). Moreover, the Japanese study [10] provides
the lowest delta LA (1.9 ± 13.1 years) (Fig. 5C).
Our suggestion is in line with the international guidelines
where it is recommended that the reference equation that pro-
vides the sum of residuals (observed–predicted computed for
each adult subject) closest to zero will be the most appropriate
for a local laboratory [16]. In practice, we would recommendthe ﬁve-step procedure, explained in Fig. 6, when judging the
abnormality in ELA.
Conclusion
In conclusion, published and locally applied spirometric refer-
ence equations for ELA did not reliably predict CLA data in
Tunisian healthy adult subjects. Among the published refer-
ence equations [7–10], and waiting the establishment of reliable
equation proper to North African population, we recommend
the use of the equation presented by Yamaguchi et al. [10].
Since the genetic and phenotypic differences among the popu-
lations are considerable and affect the prediction, we
recommend
(1) To establish novel North African regression equations
allowing prediction of the reference value of ELA and
its normal limits using data from a large number of
healthy Tunisian never-smokers with normal spiromet-
ric measurements; and
(2) To validate the developed equations using data obtained
from another group of healthy never-smokers with nor-
mal spirometry and groups of subjects with deteriorat-
ing pulmonary function such as chronic obstructive
pulmonary disease patients.
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